Relapsing Malaria (Plasmodium vivax/Plasmodium ovale)
Overview
Plain-Language Overview
Relapsing Malaria (Plasmodium vivax/Plasmodium ovale) is a type of malaria infection that affects the blood and liver. It is caused by parasites that can hide in the liver and cause repeated episodes of illness over time. These episodes include symptoms like fever, chills, sweating, and fatigue. The infection can come back weeks to months after the initial illness because the parasites remain dormant in the liver. This condition mainly impacts the immune system and red blood cells, leading to cycles of sickness. It is important to recognize because the relapses can cause ongoing health problems if not properly treated.
Clinical Definition
Relapsing Malaria (Plasmodium vivax/Plasmodium ovale) is characterized by recurrent febrile episodes caused by the reactivation of dormant hypnozoites in the liver. These parasites belong to the genus Plasmodium and specifically include P. vivax and P. ovale. The core pathology involves initial infection of hepatocytes followed by blood-stage infection of erythrocytes, leading to cyclical hemolysis and systemic symptoms. The major clinical significance lies in the parasite's ability to cause relapses weeks to months after the primary infection, complicating eradication efforts. The disease primarily affects the hematologic and immune systems, causing anemia and systemic inflammatory responses. Diagnosis and management require awareness of the parasite's unique life cycle and potential for latency.
Inciting Event
Initial infection occurs via bite of an infected female Anopheles mosquito.
Reactivation of dormant hypnozoites in the liver triggers relapse episodes.
Incomplete or inadequate treatment of primary infection allows persistence of hypnozoites.
Immunosuppressive events or stress may precipitate hypnozoite activation.
Latency Period
Relapse can occur weeks to months after initial infection due to hypnozoite dormancy.
Typical latency ranges from 3 weeks to 1 year, but can extend longer in some cases.
Multiple relapses may occur at irregular intervals over several years without re-exposure.
Diagnostic Delay
Relapsing fever episodes may be misattributed to viral infections or other febrile illnesses.
Low parasitemia during relapse can cause false-negative blood smears.
Lack of travel history or exposure awareness delays suspicion of Plasmodium vivax/ovale.
Failure to recognize the significance of prior malaria infection leads to missed diagnosis.
Clinical Presentation
Signs & Symptoms
Relapsing febrile episodes with chills, sweats, and rigors occurring weeks to months after initial infection
Fatigue and malaise from anemia and systemic illness
Headache and myalgias during febrile paroxysms
Splenic tenderness or fullness
Nausea and abdominal discomfort
History of Present Illness
Patients report recurrent episodes of fever, chills, and sweats separated by symptom-free intervals.
Each febrile episode typically lasts 48-72 hours with characteristic tertian periodicity.
Associated symptoms include headache, malaise, myalgias, and nausea during febrile paroxysms.
Splenomegaly and pallor may develop with repeated hemolytic episodes.
Past Medical History
Previous diagnosis or treatment of malaria increases suspicion for relapse.
History of travel to or residence in endemic areas is critical.
Prior use of antimalarials without radical cure (e.g., no primaquine) predisposes to relapse.
G6PD deficiency status is important due to treatment implications.
Family History
No direct hereditary transmission of malaria occurs, but family members may share exposure risk.
Genetic traits such as sickle cell trait or G6PD deficiency may cluster in families and affect disease course.
No familial syndromes are associated with relapsing malaria.
Physical Exam Findings
Fever with periodicity corresponding to parasite life cycle stages
Splenomegaly due to immune response and clearance of infected erythrocytes
Pallor from anemia caused by hemolysis
Jaundice from hemolysis and hepatic involvement
Tachycardia and tachypnea secondary to anemia and fever
Diagnostic Workup
Diagnostic Criteria
Diagnosis is established by identifying Plasmodium vivax or Plasmodium ovale parasites on peripheral blood smear during febrile episodes. Confirmation includes detection of characteristic ring forms and schizonts in erythrocytes. A history of recurrent febrile illness following travel to endemic areas supports the diagnosis. Molecular methods such as PCR can confirm species identification and detect low-level parasitemia. The presence of hypnozoite-induced relapses distinguishes this condition from other malaria types.
Pathophysiology
Key Mechanisms
Dormant hypnozoites in hepatocytes cause periodic reactivation and bloodstream infection.
Erythrocytic schizogony leads to cyclic hemolysis and fever spikes.
Immune evasion by antigenic variation allows repeated relapses.
Destruction of infected red blood cells causes anemia and splenomegaly.
Release of proinflammatory cytokines during schizont rupture triggers febrile paroxysms.
| Involvement | Details |
|---|---|
| Organs | Liver serves as the reservoir for dormant hypnozoites and is critical in the relapse mechanism of Plasmodium vivax and Plasmodium ovale. |
Spleen filters infected erythrocytes and contributes to immune clearance but may enlarge during infection. | |
Brain can be affected in severe malaria causing cerebral complications, although less common in relapsing species. | |
| Tissues | Liver tissue is the site of dormant hypnozoite forms causing relapsing infection. |
Bone marrow may be involved in anemia due to dyserythropoiesis during malaria. | |
| Cells | Hepatocytes harbor dormant hypnozoites responsible for relapse in relapsing malaria. |
Erythrocytes are invaded by blood-stage parasites causing hemolysis and clinical symptoms. | |
Kupffer cells in the liver participate in immune clearance of infected cells. | |
| Chemical Mediators | Interferon-gamma is produced by immune cells and activates macrophages to kill intracellular parasites. |
Tumor necrosis factor-alpha contributes to fever and systemic inflammation during malaria infection. | |
Interleukin-10 modulates immune response to limit tissue damage during infection. |
Treatments
Pharmacological Treatments
Chloroquine
- Mechanism:
Inhibits heme polymerase in the parasite's food vacuole, leading to toxic heme accumulation and parasite death.
- Side effects:
Retinopathy
Pruritus
Gastrointestinal upset
- Clinical role:
First-line
Primaquine
- Mechanism:
Targets dormant hypnozoites in the liver by generating reactive oxygen species that damage parasite DNA.
- Side effects:
Hemolytic anemia in G6PD deficiency
Methemoglobinemia
Gastrointestinal upset
- Clinical role:
First-line
Tafenoquine
- Mechanism:
Acts similarly to primaquine by eliminating liver hypnozoites through oxidative stress.
- Side effects:
Hemolytic anemia in G6PD deficiency
Headache
Nausea
- Clinical role:
First-line
Non-pharmacological Treatments
Use of insecticide-treated bed nets to prevent mosquito bites and reduce transmission.
Environmental control measures to reduce mosquito breeding sites such as stagnant water removal.
Prevention
Pharmacological Prevention
Primaquine for radical cure targeting hypnozoites in the liver
Chloroquine prophylaxis in endemic areas
Atovaquone-proguanil as alternative prophylaxis
Mefloquine for chemoprophylaxis in resistant regions
Doxycycline for prophylaxis in travelers
Non-pharmacological Prevention
Use of insecticide-treated bed nets to reduce mosquito bites
Indoor residual spraying with insecticides
Elimination of standing water to reduce mosquito breeding sites
Wearing protective clothing during peak mosquito activity
Screening and treatment of infected individuals to reduce transmission
Outcome & Complications
Complications
Severe anemia requiring transfusion
Splenic rupture from massive splenomegaly
Acute respiratory distress syndrome (ARDS) in severe cases
Hypoglycemia during treatment with quinine or severe infection
Secondary bacterial infections
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Relapsing Malaria (Plasmodium vivax/Plasmodium ovale) versus Plasmodium falciparum Malaria
Relapsing Malaria (Plasmodium vivax/Plasmodium ovale) | Plasmodium falciparum Malaria |
|---|---|
Infection with Plasmodium vivax or Plasmodium ovale, which form dormant hypnozoites causing relapse | Infection with Plasmodium falciparum, which does not form hypnozoites |
Characterized by relapsing febrile episodes due to hypnozoite reactivation weeks to months after initial infection | Typically causes severe, potentially fatal malaria with continuous fever spikes without true relapse |
Peripheral blood smear shows enlarged infected erythrocytes with amoeboid trophozoites and Schüffner dots | Peripheral blood smear shows multiple ring forms per erythrocyte and crescent-shaped gametocytes |
Relapsing Malaria (Plasmodium vivax/Plasmodium ovale) versus Babesiosis
Relapsing Malaria (Plasmodium vivax/Plasmodium ovale) | Babesiosis |
|---|---|
Caused by Plasmodium vivax or ovale transmitted by Anopheles mosquitoes | Caused by Babesia species transmitted by Ixodes ticks |
Blood smear shows intraerythrocytic ring forms with brown pigment and Schüffner dots | Blood smear shows intraerythrocytic ring forms often in tetrads (Maltese cross) without pigment |
Exposure to Anopheles mosquito bites in tropical or subtropical regions | Exposure to tick bites in endemic areas such as northeastern United States |
Relapsing Malaria (Plasmodium vivax/Plasmodium ovale) versus Chronic Hepatitis B Infection
Relapsing Malaria (Plasmodium vivax/Plasmodium ovale) | Chronic Hepatitis B Infection |
|---|---|
Relapsing febrile paroxysms with intermittent symptom-free intervals | Chronic liver inflammation with fluctuating transaminases over months to years |
Normal liver enzymes between attacks and positive blood smear for parasites | Elevated liver enzymes and positive hepatitis B surface antigen |
Positive rapid diagnostic test or PCR for Plasmodium vivax or ovale DNA | Positive hepatitis B viral DNA by PCR |
Relapsing Malaria (Plasmodium vivax/Plasmodium ovale) versus Typhoid Fever
Relapsing Malaria (Plasmodium vivax/Plasmodium ovale) | Typhoid Fever |
|---|---|
Exposure to Anopheles mosquito bites in endemic regions | Ingestion of contaminated food or water in endemic areas |
Relapsing fever with paroxysms separated by symptom-free intervals | Prolonged fever with stepwise temperature increase and abdominal symptoms |
Positive blood smear or antigen test for Plasmodium vivax or ovale | Positive blood culture for Salmonella typhi |
Relapsing Malaria (Plasmodium vivax/Plasmodium ovale) versus Viral Hemorrhagic Fever
Relapsing Malaria (Plasmodium vivax/Plasmodium ovale) | Viral Hemorrhagic Fever |
|---|---|
Relapsing febrile episodes without hemorrhagic manifestations | Rapid onset of high fever with bleeding diathesis and multi-organ failure |
Anemia and parasitemia on blood smear without viral markers | Thrombocytopenia, elevated liver enzymes, and positive viral PCR |
Exposure to Anopheles mosquitoes in malaria-endemic regions | Exposure to infected animals or vectors in endemic areas for viral hemorrhagic fevers |